SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Total Non-Current Assets | ₹306 Cr | ₹307 Cr | ₹244 Cr | ₹375 Cr |
What is the latest Total Non-Current Assets ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2026 | ₹306 Cr |
| Mar2025 | ₹307 Cr |
| Mar2024 | ₹244 Cr |
| Mar2023 | ₹375 Cr |
How is Total Non-Current Assets of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹306 Cr | -0.28 | |
| Mar2025 | ₹307 Cr | 25.63 | |
| Mar2024 | ₹244 Cr | -34.86 | |
| Mar2023 | ₹375 Cr | - | |
Compare Total Non-Current Assets of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹6,116.8 Cr | 1.7% | 0.2% | 49.6% | Stock Analytics | |
| PRIME FOCUS | ₹21,618.8 Cr | 6.2% | -13% | 70.6% | Stock Analytics | |
| SAGILITY | ₹21,234.5 Cr | 3.2% | -0.6% | 2.1% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹15,492.8 Cr | 10.5% | 1.5% | -38.8% | Stock Analytics | |
| INDEGENE | ₹14,277.0 Cr | 2.1% | 3.7% | 7.9% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹13,885.3 Cr | 4% | 2.6% | -8.5% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 1.7% |
0.2% |
49.6% |
| SENSEX | 3.8% |
-0.6% |
-9.1% |
You may also like the below Video Courses